Only symptoms associated with at least one abnormal metabolite are shown. This is based on Gut bacteria only.
Reset to AllBased on self-reporting
Name | Low | High | Average | Count |
---|---|---|---|---|
Amino acid metabolism: D-Arginine and D-ornithine metabolism | 1 | 0 | 0.55 | 2 |
Bacterial Abilities: Phagosome | 1 | 0 | 0.5 | 2 |
Bacterial Abilities: Sporulation | 1 | 0 | 0.9125 | 2 |
Lipid metabolism: alpha-Linolenic acid metabolism | 1 | 0 | 0.65 | 2 |
Lipid metabolism: Arachidonic acid metabolism | 1 | 1 | 0.875 | 2 |
Lipid metabolism: Biosynthesis of unsaturated fatty acids | 1 | 1 | 0.7125 | 2 |
Lipid metabolism: Ether lipid metabolism | 2 | 0 | 0.33749999999999997 | 2 |
Lipid metabolism: Steroid biosynthesis | 1 | 1 | 2.5 | 2 |
Lipid metabolism: Synthesis and degradation of ketone bodies | 2 | 0 | 0.825 | 2 |
Secondary metabolite biosynthesis: Betalain biosynthesis | 1 | 1 | 2 | 2 |
Secondary metabolite biosynthesis: Caffeine metabolism | 1 | 1 | 2.5 | 2 |
Secondary metabolite biosynthesis: Flavone and flavonol biosynthesis | 1 | 1 | 1.1875 | 2 |
Secondary metabolite biosynthesis: Indole alkaloid biosynthesis | 1 | 1 | 2 | 2 |
Secondary metabolite biosynthesis: Stilbenoid, diarylheptanoid and gingerol biosynthesis | 1 | 1 | 1.5375 | 2 |
Secondary metabolite degradation: Atrazine degradation | 1 | 1 | 1.6625 | 2 |
Secondary metabolite degradation: Benzoate degradation | 1 | 0 | 0.9125 | 2 |
Secondary metabolite degradation: Caprolactam degradation | 1 | 1 | 1.1875 | 2 |
Secondary metabolite degradation: Chloroalkane and chloroalkene degradation | 1 | 0 | 0.9125 | 2 |
Secondary metabolite degradation: Dioxin degradation | 2 | 0 | 0.825 | 2 |
Secondary metabolite degradation: Drug metabolism - cytochrome P450 | 1 | 1 | 1.125 | 2 |
Secondary metabolite degradation: Fluorobenzoate degradation | 1 | 1 | 2.5 | 2 |
Secondary metabolite degradation: Xylene degradation | 1 | 0 | 0.9125 | 2 |